Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glaucoma | 127 | 2024 | 1185 | 16.500 |
Why?
|
Glaucoma, Angle-Closure | 98 | 2024 | 190 | 15.290 |
Why?
|
Intraocular Pressure | 151 | 2024 | 1294 | 10.720 |
Why?
|
Glaucoma, Open-Angle | 60 | 2024 | 738 | 7.030 |
Why?
|
Vision Disorders | 56 | 2024 | 1088 | 5.980 |
Why?
|
Refractive Errors | 26 | 2022 | 147 | 5.550 |
Why?
|
Tonometry, Ocular | 46 | 2021 | 235 | 5.350 |
Why?
|
Visual Fields | 68 | 2024 | 1062 | 5.150 |
Why?
|
Visual Acuity | 97 | 2023 | 2672 | 4.960 |
Why?
|
Vision Screening | 18 | 2024 | 72 | 4.770 |
Why?
|
Diagnostic Techniques, Ophthalmological | 19 | 2021 | 251 | 4.470 |
Why?
|
Ocular Hypertension | 31 | 2023 | 209 | 4.420 |
Why?
|
Iris | 44 | 2024 | 232 | 4.190 |
Why?
|
Gonioscopy | 69 | 2024 | 155 | 3.830 |
Why?
|
Iridectomy | 30 | 2024 | 48 | 3.620 |
Why?
|
Visual Field Tests | 33 | 2024 | 411 | 3.370 |
Why?
|
Trabeculectomy | 21 | 2023 | 174 | 3.320 |
Why?
|
Anterior Eye Segment | 34 | 2024 | 143 | 3.270 |
Why?
|
Eyeglasses | 17 | 2022 | 137 | 3.190 |
Why?
|
Vision, Low | 17 | 2024 | 163 | 3.030 |
Why?
|
Visually Impaired Persons | 15 | 2020 | 78 | 2.970 |
Why?
|
Cataract Extraction | 23 | 2023 | 467 | 2.960 |
Why?
|
Homes for the Aged | 9 | 2024 | 273 | 2.880 |
Why?
|
Refraction, Ocular | 21 | 2022 | 184 | 2.860 |
Why?
|
Anterior Chamber | 24 | 2021 | 194 | 2.700 |
Why?
|
Laser Therapy | 27 | 2023 | 1092 | 2.670 |
Why?
|
Optic Nerve Diseases | 17 | 2023 | 342 | 2.460 |
Why?
|
Antihypertensive Agents | 26 | 2019 | 2016 | 2.420 |
Why?
|
Accidental Falls | 18 | 2024 | 1065 | 2.380 |
Why?
|
Tomography, Optical Coherence | 70 | 2024 | 2916 | 2.340 |
Why?
|
Eye Diseases | 17 | 2021 | 653 | 2.150 |
Why?
|
Cataract | 21 | 2023 | 831 | 2.070 |
Why?
|
Pupil | 13 | 2019 | 145 | 2.000 |
Why?
|
Ophthalmology | 16 | 2024 | 550 | 1.910 |
Why?
|
Blindness | 20 | 2023 | 584 | 1.900 |
Why?
|
Reflex, Pupillary | 5 | 2019 | 62 | 1.710 |
Why?
|
Diabetic Retinopathy | 14 | 2020 | 1273 | 1.700 |
Why?
|
Rural Population | 27 | 2020 | 2276 | 1.570 |
Why?
|
Trabecular Meshwork | 17 | 2018 | 101 | 1.560 |
Why?
|
Patient Compliance | 14 | 2019 | 2688 | 1.490 |
Why?
|
Lasers, Solid-State | 10 | 2022 | 176 | 1.480 |
Why?
|
Baltimore | 16 | 2022 | 231 | 1.450 |
Why?
|
Cloprostenol | 7 | 2013 | 21 | 1.420 |
Why?
|
Phacoemulsification | 8 | 2023 | 149 | 1.420 |
Why?
|
Myopia | 10 | 2023 | 252 | 1.410 |
Why?
|
Ophthalmic Solutions | 11 | 2015 | 312 | 1.290 |
Why?
|
Optic Disk | 17 | 2023 | 421 | 1.280 |
Why?
|
Chloral Hydrate | 2 | 2018 | 28 | 1.250 |
Why?
|
Aged | 217 | 2024 | 169042 | 1.210 |
Why?
|
Lens, Crystalline | 8 | 2022 | 387 | 1.180 |
Why?
|
Cross-Sectional Studies | 100 | 2024 | 26049 | 1.180 |
Why?
|
China | 45 | 2024 | 2374 | 1.160 |
Why?
|
Mydriasis | 3 | 2024 | 14 | 1.150 |
Why?
|
Photography | 13 | 2017 | 532 | 1.090 |
Why?
|
Fear | 9 | 2024 | 1477 | 1.060 |
Why?
|
Prospective Studies | 96 | 2024 | 54360 | 1.060 |
Why?
|
Humans | 387 | 2024 | 760617 | 1.050 |
Why?
|
India | 19 | 2024 | 2286 | 1.050 |
Why?
|
Middle Aged | 214 | 2024 | 220584 | 1.040 |
Why?
|
Male | 272 | 2024 | 360358 | 1.040 |
Why?
|
Vision Tests | 9 | 2020 | 161 | 1.030 |
Why?
|
Female | 279 | 2024 | 392148 | 1.030 |
Why?
|
Prevalence | 63 | 2024 | 15689 | 0.990 |
Why?
|
Medicare Part B | 4 | 2014 | 117 | 0.990 |
Why?
|
Urban Population | 12 | 2018 | 2033 | 0.990 |
Why?
|
Drug Monitoring | 6 | 2014 | 960 | 0.940 |
Why?
|
Retinal Ganglion Cells | 6 | 2023 | 810 | 0.930 |
Why?
|
Conscious Sedation | 2 | 2018 | 531 | 0.890 |
Why?
|
Reminder Systems | 3 | 2019 | 386 | 0.870 |
Why?
|
Sickness Impact Profile | 10 | 2020 | 299 | 0.860 |
Why?
|
Maryland | 16 | 2018 | 277 | 0.830 |
Why?
|
Schools | 8 | 2022 | 1483 | 0.830 |
Why?
|
Medication Adherence | 8 | 2019 | 2174 | 0.820 |
Why?
|
Microscopy, Acoustic | 7 | 2013 | 47 | 0.820 |
Why?
|
Aged, 80 and over | 95 | 2024 | 58894 | 0.800 |
Why?
|
Monitoring, Ambulatory | 2 | 2021 | 355 | 0.800 |
Why?
|
Pupil Disorders | 3 | 2022 | 32 | 0.790 |
Why?
|
Accidents, Home | 2 | 2019 | 71 | 0.770 |
Why?
|
Health Services | 6 | 2019 | 751 | 0.770 |
Why?
|
Biometry | 22 | 2023 | 561 | 0.760 |
Why?
|
Corneal Wavefront Aberration | 1 | 2021 | 7 | 0.760 |
Why?
|
Nerve Fibers | 4 | 2023 | 707 | 0.750 |
Why?
|
Aberrometry | 1 | 2021 | 7 | 0.750 |
Why?
|
Diabetes Complications | 5 | 2016 | 1315 | 0.730 |
Why?
|
Appointments and Schedules | 2 | 2021 | 442 | 0.700 |
Why?
|
Distance Perception | 1 | 2020 | 18 | 0.700 |
Why?
|
Hypnotics and Sedatives | 2 | 2018 | 1178 | 0.700 |
Why?
|
Reading | 7 | 2021 | 531 | 0.690 |
Why?
|
Age Distribution | 24 | 2024 | 2871 | 0.690 |
Why?
|
Lens Implantation, Intraocular | 9 | 2020 | 191 | 0.690 |
Why?
|
Lighting | 2 | 2021 | 211 | 0.690 |
Why?
|
Nutrition Surveys | 8 | 2024 | 1723 | 0.680 |
Why?
|
Telemetry | 1 | 2021 | 199 | 0.670 |
Why?
|
Limbus Corneae | 1 | 2021 | 143 | 0.670 |
Why?
|
Conjunctiva | 3 | 2019 | 479 | 0.670 |
Why?
|
Prostaglandins F, Synthetic | 5 | 2014 | 32 | 0.670 |
Why?
|
Cornea | 13 | 2023 | 1332 | 0.660 |
Why?
|
Sex Distribution | 21 | 2024 | 2278 | 0.640 |
Why?
|
Health Services Accessibility | 12 | 2022 | 5430 | 0.640 |
Why?
|
Allied Health Personnel | 1 | 2020 | 155 | 0.640 |
Why?
|
Dark Adaptation | 2 | 2019 | 222 | 0.620 |
Why?
|
Fluocinolone Acetonide | 2 | 2020 | 38 | 0.610 |
Why?
|
Exercise | 13 | 2024 | 5886 | 0.600 |
Why?
|
Community Health Services | 4 | 2021 | 654 | 0.600 |
Why?
|
Macular Degeneration | 12 | 2018 | 1007 | 0.580 |
Why?
|
Risk Factors | 70 | 2024 | 74115 | 0.570 |
Why?
|
Hyperopia | 4 | 2022 | 41 | 0.570 |
Why?
|
Morbidity | 7 | 2020 | 1750 | 0.560 |
Why?
|
Singapore | 20 | 2021 | 292 | 0.560 |
Why?
|
Reference Standards | 1 | 2020 | 1002 | 0.550 |
Why?
|
Surgical Stomas | 1 | 2016 | 42 | 0.540 |
Why?
|
Adult | 103 | 2024 | 220969 | 0.530 |
Why?
|
Disability Evaluation | 5 | 2020 | 1835 | 0.520 |
Why?
|
Ophthalmologic Surgical Procedures | 4 | 2022 | 354 | 0.520 |
Why?
|
ROC Curve | 17 | 2024 | 3575 | 0.510 |
Why?
|
Telemedicine | 7 | 2021 | 3050 | 0.510 |
Why?
|
Quality of Life | 22 | 2023 | 13347 | 0.500 |
Why?
|
Mass Screening | 7 | 2024 | 5424 | 0.500 |
Why?
|
Reproducibility of Results | 29 | 2023 | 20074 | 0.490 |
Why?
|
Glaucoma Drainage Implants | 3 | 2023 | 107 | 0.470 |
Why?
|
Counseling | 2 | 2021 | 1538 | 0.460 |
Why?
|
Telecommunications | 1 | 2014 | 79 | 0.450 |
Why?
|
Mobility Limitation | 1 | 2018 | 408 | 0.450 |
Why?
|
Ambulatory Care Facilities | 2 | 2022 | 934 | 0.440 |
Why?
|
Contrast Sensitivity | 7 | 2019 | 253 | 0.440 |
Why?
|
Automobile Driving | 5 | 2020 | 441 | 0.440 |
Why?
|
Independent Living | 1 | 2018 | 577 | 0.440 |
Why?
|
Nursing Homes | 4 | 2005 | 1083 | 0.430 |
Why?
|
Medicare Part A | 1 | 2013 | 40 | 0.430 |
Why?
|
Blood Pressure | 7 | 2019 | 8472 | 0.430 |
Why?
|
Follow-Up Studies | 38 | 2024 | 39063 | 0.420 |
Why?
|
Patient Education as Topic | 7 | 2019 | 2315 | 0.420 |
Why?
|
Retina | 5 | 2023 | 2655 | 0.420 |
Why?
|
False Positive Reactions | 9 | 2020 | 957 | 0.410 |
Why?
|
Axial Length, Eye | 7 | 2019 | 35 | 0.410 |
Why?
|
Managed Care Programs | 4 | 2008 | 937 | 0.400 |
Why?
|
Physical Examination | 1 | 2018 | 1254 | 0.390 |
Why?
|
Computers, Handheld | 1 | 2014 | 210 | 0.390 |
Why?
|
Motor Activity | 5 | 2019 | 2714 | 0.390 |
Why?
|
Activities of Daily Living | 7 | 2020 | 2417 | 0.390 |
Why?
|
Travel | 3 | 2015 | 796 | 0.390 |
Why?
|
Insurance Benefits | 1 | 2013 | 187 | 0.380 |
Why?
|
Patient Satisfaction | 11 | 2022 | 3451 | 0.380 |
Why?
|
Mydriatics | 5 | 2022 | 67 | 0.370 |
Why?
|
Retinal Diseases | 3 | 2012 | 704 | 0.370 |
Why?
|
Sensitivity and Specificity | 17 | 2021 | 14648 | 0.370 |
Why?
|
United States | 40 | 2024 | 72272 | 0.360 |
Why?
|
Amblyopia | 2 | 2010 | 150 | 0.360 |
Why?
|
Program Evaluation | 2 | 2022 | 2486 | 0.350 |
Why?
|
Health Knowledge, Attitudes, Practice | 8 | 2020 | 4007 | 0.340 |
Why?
|
Sclera | 5 | 2016 | 190 | 0.340 |
Why?
|
Physician-Patient Relations | 5 | 2015 | 3239 | 0.340 |
Why?
|
Attitude to Health | 5 | 2011 | 2024 | 0.340 |
Why?
|
Retrospective Studies | 46 | 2024 | 80566 | 0.330 |
Why?
|
Administration, Topical | 7 | 2015 | 703 | 0.330 |
Why?
|
Uveitis | 1 | 2013 | 396 | 0.330 |
Why?
|
Geographic Information Systems | 1 | 2011 | 281 | 0.330 |
Why?
|
Health Surveys | 11 | 2018 | 4037 | 0.320 |
Why?
|
Medically Underserved Area | 1 | 2011 | 254 | 0.310 |
Why?
|
Glucocorticoids | 2 | 2020 | 2160 | 0.310 |
Why?
|
Patient Acceptance of Health Care | 5 | 2019 | 3194 | 0.310 |
Why?
|
Eye Injuries | 3 | 2021 | 227 | 0.300 |
Why?
|
Triglycerides | 1 | 2016 | 2459 | 0.300 |
Why?
|
Pseudophakia | 4 | 2020 | 60 | 0.300 |
Why?
|
Actigraphy | 1 | 2012 | 521 | 0.300 |
Why?
|
Area Under Curve | 11 | 2024 | 1635 | 0.300 |
Why?
|
Vulnerable Populations | 1 | 2013 | 704 | 0.290 |
Why?
|
Drug Utilization Review | 2 | 2008 | 248 | 0.290 |
Why?
|
Fundus Oculi | 3 | 2019 | 556 | 0.290 |
Why?
|
Dyslexia | 1 | 2009 | 208 | 0.280 |
Why?
|
Strabismus | 3 | 2012 | 317 | 0.280 |
Why?
|
Insurance Claim Review | 3 | 2008 | 741 | 0.280 |
Why?
|
Vision, Ocular | 4 | 2019 | 454 | 0.270 |
Why?
|
Fixation, Ocular | 1 | 2008 | 242 | 0.270 |
Why?
|
Reoperation | 5 | 2021 | 4300 | 0.270 |
Why?
|
Eye Abnormalities | 2 | 2023 | 242 | 0.260 |
Why?
|
Disease Progression | 16 | 2024 | 13495 | 0.260 |
Why?
|
Evidence-Based Medicine | 7 | 2017 | 3680 | 0.260 |
Why?
|
Insurance, Major Medical | 1 | 2005 | 12 | 0.260 |
Why?
|
Models, Statistical | 5 | 2013 | 5073 | 0.260 |
Why?
|
Child | 25 | 2023 | 80079 | 0.260 |
Why?
|
Drug Utilization | 4 | 2015 | 1186 | 0.260 |
Why?
|
Ciliary Body | 6 | 2021 | 167 | 0.260 |
Why?
|
Health Services for the Aged | 2 | 2005 | 258 | 0.260 |
Why?
|
Dementia | 1 | 2020 | 2680 | 0.250 |
Why?
|
Universities | 1 | 2011 | 992 | 0.250 |
Why?
|
Acute Disease | 9 | 2023 | 7237 | 0.250 |
Why?
|
Health Insurance Portability and Accountability Act | 1 | 2006 | 105 | 0.250 |
Why?
|
Family Health | 4 | 2021 | 1253 | 0.250 |
Why?
|
Healthcare Disparities | 4 | 2021 | 3351 | 0.250 |
Why?
|
Educational Status | 7 | 2022 | 2509 | 0.240 |
Why?
|
Operating Rooms | 3 | 2021 | 789 | 0.230 |
Why?
|
Low Tension Glaucoma | 1 | 2024 | 24 | 0.230 |
Why?
|
Child, Preschool | 14 | 2024 | 42188 | 0.230 |
Why?
|
Astigmatism | 3 | 2021 | 68 | 0.230 |
Why?
|
Young Adult | 17 | 2023 | 59179 | 0.230 |
Why?
|
Population Surveillance | 4 | 2021 | 2595 | 0.230 |
Why?
|
Diabetes Mellitus | 7 | 2020 | 5835 | 0.230 |
Why?
|
Hypertension | 4 | 2020 | 8529 | 0.220 |
Why?
|
Movement Disorders | 1 | 2007 | 459 | 0.220 |
Why?
|
Predictive Value of Tests | 12 | 2024 | 15251 | 0.220 |
Why?
|
Bangladesh | 2 | 2019 | 732 | 0.220 |
Why?
|
Cell Count | 3 | 2019 | 1835 | 0.220 |
Why?
|
Cohort Studies | 19 | 2024 | 41457 | 0.220 |
Why?
|
Blister | 3 | 2009 | 86 | 0.220 |
Why?
|
Risk Assessment | 13 | 2024 | 23972 | 0.210 |
Why?
|
Smoking | 3 | 2019 | 9050 | 0.210 |
Why?
|
Adolescent | 17 | 2023 | 88234 | 0.210 |
Why?
|
Laser Coagulation | 2 | 2016 | 330 | 0.210 |
Why?
|
Patient-Centered Care | 2 | 2010 | 1418 | 0.210 |
Why?
|
Communication | 4 | 2015 | 3849 | 0.210 |
Why?
|
Vision, Binocular | 4 | 2013 | 226 | 0.200 |
Why?
|
Physicians | 1 | 2020 | 4583 | 0.200 |
Why?
|
Presbyopia | 1 | 2022 | 10 | 0.200 |
Why?
|
Incidence | 15 | 2021 | 21337 | 0.200 |
Why?
|
Manufactured Materials | 3 | 2012 | 18 | 0.200 |
Why?
|
Emergency Service, Hospital | 4 | 2021 | 7871 | 0.200 |
Why?
|
Drug Packaging | 2 | 2015 | 43 | 0.200 |
Why?
|
Oxygen Consumption | 2 | 2018 | 1866 | 0.190 |
Why?
|
School Nursing | 1 | 2021 | 33 | 0.190 |
Why?
|
Drug Prescriptions | 3 | 2007 | 1669 | 0.190 |
Why?
|
Age Factors | 11 | 2020 | 18381 | 0.190 |
Why?
|
Eye | 3 | 2010 | 712 | 0.190 |
Why?
|
Phenylephrine | 1 | 2022 | 293 | 0.190 |
Why?
|
Developing Countries | 2 | 2011 | 2867 | 0.190 |
Why?
|
Choroid | 3 | 2014 | 360 | 0.180 |
Why?
|
Electronic Health Records | 4 | 2024 | 4803 | 0.180 |
Why?
|
Health Promotion | 3 | 2022 | 2206 | 0.180 |
Why?
|
Gait | 3 | 2021 | 811 | 0.180 |
Why?
|
Health Care Costs | 2 | 2013 | 3238 | 0.180 |
Why?
|
Uveitis, Intermediate | 1 | 2020 | 17 | 0.180 |
Why?
|
Odds Ratio | 8 | 2019 | 9643 | 0.180 |
Why?
|
Exfoliation Syndrome | 3 | 2018 | 113 | 0.180 |
Why?
|
Uveitis, Posterior | 1 | 2020 | 45 | 0.180 |
Why?
|
Filtering Surgery | 2 | 2015 | 33 | 0.180 |
Why?
|
Aging | 6 | 2018 | 8699 | 0.170 |
Why?
|
Panuveitis | 1 | 2020 | 33 | 0.170 |
Why?
|
Randomized Controlled Trials as Topic | 8 | 2021 | 10199 | 0.170 |
Why?
|
Light | 6 | 2012 | 1352 | 0.170 |
Why?
|
Hospitals, Special | 1 | 2020 | 91 | 0.170 |
Why?
|
Siblings | 3 | 2021 | 824 | 0.170 |
Why?
|
Color Vision | 1 | 2019 | 23 | 0.170 |
Why?
|
Economics, Medical | 1 | 2020 | 112 | 0.170 |
Why?
|
Video Recording | 5 | 2012 | 965 | 0.170 |
Why?
|
Suture Techniques | 2 | 2019 | 768 | 0.170 |
Why?
|
Psychomotor Performance | 1 | 2007 | 1882 | 0.160 |
Why?
|
Lenses, Intraocular | 2 | 2019 | 139 | 0.160 |
Why?
|
Polymorphism, Single Nucleotide | 7 | 2018 | 15908 | 0.160 |
Why?
|
Treatment Outcome | 21 | 2023 | 64568 | 0.160 |
Why?
|
Functional Laterality | 4 | 2010 | 2256 | 0.160 |
Why?
|
Biomedical Technology | 1 | 2021 | 210 | 0.160 |
Why?
|
Artificial Intelligence | 3 | 2023 | 2574 | 0.160 |
Why?
|
Infant | 10 | 2021 | 36152 | 0.150 |
Why?
|
Hospitals, Rural | 3 | 2015 | 176 | 0.150 |
Why?
|
Manometry | 1 | 2020 | 454 | 0.150 |
Why?
|
Prone Position | 1 | 2019 | 196 | 0.150 |
Why?
|
Optometry | 1 | 2017 | 29 | 0.150 |
Why?
|
Intention to Treat Analysis | 1 | 2019 | 413 | 0.150 |
Why?
|
School Health Services | 1 | 2021 | 384 | 0.150 |
Why?
|
Drug Implants | 2 | 2020 | 230 | 0.140 |
Why?
|
Self Report | 2 | 2020 | 3723 | 0.140 |
Why?
|
Postal Service | 1 | 2017 | 96 | 0.140 |
Why?
|
Genome-Wide Association Study | 6 | 2024 | 12661 | 0.140 |
Why?
|
Prescriptions | 2 | 2017 | 385 | 0.140 |
Why?
|
Databases, Factual | 8 | 2020 | 7960 | 0.140 |
Why?
|
Observer Variation | 9 | 2019 | 2606 | 0.140 |
Why?
|
Parents | 4 | 2021 | 3563 | 0.140 |
Why?
|
Quality Assurance, Health Care | 2 | 2019 | 2164 | 0.140 |
Why?
|
Delaware | 3 | 2005 | 12 | 0.140 |
Why?
|
Longitudinal Studies | 11 | 2023 | 14591 | 0.140 |
Why?
|
Trust | 1 | 2021 | 528 | 0.140 |
Why?
|
Heart Rate | 2 | 2018 | 4180 | 0.140 |
Why?
|
Monitoring, Physiologic | 2 | 2016 | 1779 | 0.130 |
Why?
|
Referral and Consultation | 3 | 2024 | 3599 | 0.130 |
Why?
|
Sex Factors | 9 | 2020 | 10548 | 0.130 |
Why?
|
Logistic Models | 4 | 2024 | 13245 | 0.130 |
Why?
|
Self Care | 1 | 2021 | 796 | 0.130 |
Why?
|
Research Design | 6 | 2017 | 6174 | 0.130 |
Why?
|
Insurance, Health | 3 | 2018 | 2495 | 0.130 |
Why?
|
Postural Balance | 1 | 2020 | 622 | 0.120 |
Why?
|
Postoperative Complications | 8 | 2023 | 15612 | 0.120 |
Why?
|
Scotoma | 1 | 2016 | 130 | 0.120 |
Why?
|
Fluorouracil | 3 | 2016 | 1642 | 0.120 |
Why?
|
Case-Control Studies | 10 | 2021 | 22148 | 0.120 |
Why?
|
Diagnostic Self Evaluation | 1 | 2016 | 224 | 0.120 |
Why?
|
Interferometry | 2 | 2012 | 100 | 0.110 |
Why?
|
Therapies, Investigational | 1 | 2015 | 111 | 0.110 |
Why?
|
Photic Stimulation | 2 | 2013 | 1987 | 0.110 |
Why?
|
Equipment Safety | 1 | 2015 | 249 | 0.110 |
Why?
|
Guidelines as Topic | 1 | 2020 | 1386 | 0.110 |
Why?
|
Caveolin 2 | 1 | 2013 | 25 | 0.110 |
Why?
|
Wnt Proteins | 1 | 2018 | 718 | 0.110 |
Why?
|
Geographic Atrophy | 1 | 2015 | 91 | 0.110 |
Why?
|
Clinical Competence | 3 | 2015 | 4789 | 0.110 |
Why?
|
Double-Blind Method | 4 | 2013 | 12334 | 0.110 |
Why?
|
Keratoconus | 1 | 2015 | 112 | 0.110 |
Why?
|
Genomic Structural Variation | 1 | 2013 | 68 | 0.110 |
Why?
|
Injections | 1 | 2016 | 832 | 0.110 |
Why?
|
Reflex, Abnormal | 1 | 2013 | 83 | 0.110 |
Why?
|
Pterygium | 1 | 2013 | 26 | 0.110 |
Why?
|
Needles | 1 | 2016 | 450 | 0.110 |
Why?
|
Time Factors | 14 | 2020 | 39913 | 0.110 |
Why?
|
Probability | 3 | 2013 | 2475 | 0.110 |
Why?
|
Obesity, Abdominal | 1 | 2016 | 373 | 0.100 |
Why?
|
Medical Record Linkage | 1 | 2014 | 286 | 0.100 |
Why?
|
Comparative Effectiveness Research | 2 | 2015 | 708 | 0.100 |
Why?
|
Wet Macular Degeneration | 1 | 2015 | 162 | 0.100 |
Why?
|
Child Health Services | 1 | 2018 | 644 | 0.100 |
Why?
|
Nystagmus, Congenital | 1 | 2012 | 9 | 0.100 |
Why?
|
Lens Diseases | 1 | 2012 | 13 | 0.100 |
Why?
|
Epidemiologic Studies | 1 | 2016 | 673 | 0.100 |
Why?
|
Lacrimal Apparatus Diseases | 1 | 2013 | 72 | 0.100 |
Why?
|
False Negative Reactions | 1 | 2013 | 573 | 0.100 |
Why?
|
Neural Cell Adhesion Molecules | 1 | 2012 | 122 | 0.100 |
Why?
|
Caveolin 1 | 1 | 2013 | 255 | 0.100 |
Why?
|
United States Department of Veterans Affairs | 1 | 2016 | 928 | 0.100 |
Why?
|
Cell Size | 1 | 2013 | 624 | 0.090 |
Why?
|
Amides | 2 | 2011 | 449 | 0.090 |
Why?
|
Hearing Loss | 1 | 2018 | 781 | 0.090 |
Why?
|
Students | 3 | 2021 | 1733 | 0.090 |
Why?
|
Cross-Cultural Comparison | 1 | 2014 | 634 | 0.090 |
Why?
|
Education, Medical, Graduate | 2 | 2013 | 2371 | 0.090 |
Why?
|
Health Services Research | 3 | 2007 | 1808 | 0.090 |
Why?
|
Hospitals | 2 | 2022 | 3877 | 0.090 |
Why?
|
Health Behavior | 2 | 2014 | 2643 | 0.090 |
Why?
|
Multivariate Analysis | 5 | 2019 | 12043 | 0.090 |
Why?
|
New York City | 2 | 2024 | 731 | 0.090 |
Why?
|
Biomedical Research | 1 | 2006 | 3426 | 0.090 |
Why?
|
Endothelium, Corneal | 1 | 2012 | 215 | 0.090 |
Why?
|
Scattering, Radiation | 1 | 2012 | 490 | 0.090 |
Why?
|
Treatment Failure | 1 | 2016 | 2635 | 0.090 |
Why?
|
Administration, Oral | 1 | 2018 | 4010 | 0.090 |
Why?
|
Hypotension | 1 | 2016 | 878 | 0.090 |
Why?
|
Nervous System Diseases | 1 | 2020 | 1662 | 0.090 |
Why?
|
Surgically-Created Structures | 1 | 2009 | 9 | 0.080 |
Why?
|
Quantitative Trait Loci | 1 | 2018 | 2112 | 0.080 |
Why?
|
Medicare | 3 | 2023 | 6765 | 0.080 |
Why?
|
Regression Analysis | 3 | 2013 | 6338 | 0.080 |
Why?
|
Algorithms | 6 | 2023 | 14018 | 0.080 |
Why?
|
Attitude of Health Personnel | 2 | 2021 | 3879 | 0.080 |
Why?
|
Retinal Vessels | 1 | 2015 | 852 | 0.080 |
Why?
|
Rural Health Services | 1 | 2013 | 384 | 0.080 |
Why?
|
Focus Groups | 3 | 2021 | 1409 | 0.080 |
Why?
|
Epidemiologic Methods | 2 | 2015 | 1335 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2020 | 1846 | 0.080 |
Why?
|
Lasers | 2 | 2023 | 952 | 0.080 |
Why?
|
Macula Lutea | 1 | 2010 | 177 | 0.080 |
Why?
|
Eyelids | 1 | 2011 | 278 | 0.080 |
Why?
|
Prostaglandins, Synthetic | 1 | 2008 | 24 | 0.080 |
Why?
|
Epiretinal Membrane | 1 | 2008 | 73 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6474 | 0.080 |
Why?
|
Severity of Illness Index | 4 | 2016 | 15828 | 0.080 |
Why?
|
Efficiency, Organizational | 1 | 2013 | 695 | 0.080 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2017 | 8998 | 0.070 |
Why?
|
Movement | 1 | 2015 | 1476 | 0.070 |
Why?
|
Periodicals as Topic | 1 | 2019 | 1463 | 0.070 |
Why?
|
Body Height | 1 | 2014 | 1565 | 0.070 |
Why?
|
Nerve Degeneration | 1 | 2012 | 747 | 0.070 |
Why?
|
Body Mass Index | 3 | 2016 | 12943 | 0.070 |
Why?
|
Minority Groups | 1 | 2015 | 1202 | 0.070 |
Why?
|
Iris Diseases | 1 | 2007 | 37 | 0.070 |
Why?
|
Consensus | 1 | 2017 | 3117 | 0.070 |
Why?
|
Income | 1 | 2016 | 1870 | 0.070 |
Why?
|
Corneal Diseases | 1 | 2013 | 542 | 0.070 |
Why?
|
Ambulatory Care | 1 | 2018 | 2768 | 0.070 |
Why?
|
Smoking Cessation | 1 | 2019 | 2056 | 0.070 |
Why?
|
Blood Glucose | 4 | 2014 | 6390 | 0.070 |
Why?
|
Health Status Indicators | 1 | 2012 | 969 | 0.070 |
Why?
|
United States Food and Drug Administration | 1 | 2015 | 1661 | 0.070 |
Why?
|
Estrogens | 1 | 2013 | 1521 | 0.070 |
Why?
|
Ultrasonography | 6 | 2021 | 5964 | 0.070 |
Why?
|
Nuclear Family | 1 | 2007 | 311 | 0.070 |
Why?
|
Decision Making | 2 | 2019 | 3918 | 0.070 |
Why?
|
Chronic Disease | 1 | 2021 | 9311 | 0.060 |
Why?
|
Mitomycin | 2 | 2023 | 263 | 0.060 |
Why?
|
Adiposity | 1 | 2016 | 1879 | 0.060 |
Why?
|
Geriatric Assessment | 2 | 2014 | 1411 | 0.060 |
Why?
|
Asia | 3 | 2015 | 615 | 0.060 |
Why?
|
Organ Size | 3 | 2018 | 2252 | 0.060 |
Why?
|
Health Services Needs and Demand | 1 | 2013 | 1400 | 0.060 |
Why?
|
Medicaid | 1 | 2018 | 2814 | 0.060 |
Why?
|
Education, Medical, Continuing | 1 | 2010 | 823 | 0.060 |
Why?
|
Intelligence Tests | 1 | 2005 | 503 | 0.060 |
Why?
|
Transforming Growth Factor beta | 1 | 2012 | 1963 | 0.060 |
Why?
|
Circadian Rhythm | 2 | 2016 | 2569 | 0.060 |
Why?
|
Exercise Test | 1 | 2012 | 2127 | 0.060 |
Why?
|
Aphakia, Postcataract | 1 | 2004 | 52 | 0.060 |
Why?
|
Miotics | 1 | 2003 | 9 | 0.060 |
Why?
|
Specialization | 1 | 2008 | 778 | 0.050 |
Why?
|
Uvea | 1 | 2003 | 30 | 0.050 |
Why?
|
Pilocarpine | 1 | 2003 | 64 | 0.050 |
Why?
|
Body Weight | 1 | 2014 | 4614 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 3 | 2013 | 17878 | 0.050 |
Why?
|
Republic of Korea | 2 | 2016 | 583 | 0.050 |
Why?
|
Thailand | 1 | 2023 | 287 | 0.050 |
Why?
|
Sex Characteristics | 1 | 2013 | 2637 | 0.050 |
Why?
|
Glucose | 1 | 2014 | 4345 | 0.050 |
Why?
|
Veterans | 1 | 2016 | 2649 | 0.050 |
Why?
|
Postoperative Period | 3 | 2017 | 1813 | 0.050 |
Why?
|
Photophobia | 1 | 2023 | 75 | 0.050 |
Why?
|
Primary Health Care | 1 | 2019 | 4668 | 0.050 |
Why?
|
Publications | 1 | 2004 | 194 | 0.050 |
Why?
|
Developmental Disabilities | 1 | 2011 | 1509 | 0.050 |
Why?
|
Fourier Analysis | 2 | 2013 | 440 | 0.050 |
Why?
|
Equipment Design | 1 | 2010 | 3501 | 0.050 |
Why?
|
Prognosis | 6 | 2018 | 29600 | 0.050 |
Why?
|
Hemorrhage | 2 | 2024 | 3418 | 0.050 |
Why?
|
Reference Values | 3 | 2015 | 4919 | 0.050 |
Why?
|
Chicago | 1 | 2022 | 254 | 0.050 |
Why?
|
Cluster Analysis | 2 | 2024 | 2700 | 0.050 |
Why?
|
Causality | 2 | 2004 | 1240 | 0.050 |
Why?
|
Comorbidity | 3 | 2021 | 10505 | 0.050 |
Why?
|
Anisometropia | 2 | 2011 | 17 | 0.050 |
Why?
|
World Health Organization | 2 | 2022 | 1321 | 0.050 |
Why?
|
Hospitalization | 1 | 2020 | 10704 | 0.040 |
Why?
|
Health Expenditures | 1 | 2013 | 2361 | 0.040 |
Why?
|
Chromosomes, Human, Pair 9 | 2 | 2012 | 535 | 0.040 |
Why?
|
Medicine | 1 | 2008 | 942 | 0.040 |
Why?
|
Drug Therapy | 1 | 2003 | 503 | 0.040 |
Why?
|
Weather | 1 | 2021 | 231 | 0.040 |
Why?
|
Infant, Newborn | 2 | 2020 | 26180 | 0.040 |
Why?
|
Residential Facilities | 1 | 2019 | 42 | 0.040 |
Why?
|
Motivation | 1 | 2009 | 2003 | 0.040 |
Why?
|
Nerve Tissue Proteins | 1 | 2012 | 4408 | 0.040 |
Why?
|
Africa South of the Sahara | 1 | 2022 | 745 | 0.040 |
Why?
|
Optic Nerve | 2 | 2013 | 572 | 0.040 |
Why?
|
Patient Care | 1 | 2004 | 621 | 0.040 |
Why?
|
Prosthesis Implantation | 1 | 2023 | 591 | 0.040 |
Why?
|
Guideline Adherence | 2 | 2007 | 2218 | 0.040 |
Why?
|
Genotype | 4 | 2013 | 12978 | 0.040 |
Why?
|
Prostaglandins | 2 | 2013 | 398 | 0.040 |
Why?
|
Biological Specimen Banks | 1 | 2024 | 778 | 0.040 |
Why?
|
International Classification of Diseases | 1 | 2024 | 909 | 0.040 |
Why?
|
Dilatation, Pathologic | 2 | 2010 | 527 | 0.040 |
Why?
|
Cost-Benefit Analysis | 3 | 2020 | 5491 | 0.040 |
Why?
|
Vitreous Body | 1 | 2020 | 399 | 0.040 |
Why?
|
Hospital Charges | 1 | 2020 | 350 | 0.040 |
Why?
|
Delivery of Health Care | 2 | 2021 | 5332 | 0.040 |
Why?
|
Delphi Technique | 1 | 2022 | 846 | 0.040 |
Why?
|
Microscopy | 1 | 2003 | 905 | 0.040 |
Why?
|
Clinical Trials as Topic | 2 | 2012 | 7995 | 0.040 |
Why?
|
Spinal Cord Diseases | 1 | 2020 | 291 | 0.040 |
Why?
|
Hearing Tests | 1 | 2018 | 121 | 0.040 |
Why?
|
Quality Improvement | 1 | 2013 | 3797 | 0.040 |
Why?
|
Linear Models | 2 | 2021 | 5866 | 0.040 |
Why?
|
Alleles | 3 | 2013 | 6861 | 0.040 |
Why?
|
Quality of Health Care | 3 | 2021 | 4321 | 0.040 |
Why?
|
Pandemics | 3 | 2021 | 8645 | 0.040 |
Why?
|
Advisory Committees | 1 | 2021 | 787 | 0.030 |
Why?
|
Neurotoxicity Syndromes | 1 | 2020 | 301 | 0.030 |
Why?
|
Family | 1 | 2007 | 3193 | 0.030 |
Why?
|
Educational Measurement | 2 | 2013 | 1252 | 0.030 |
Why?
|
Lightning | 1 | 2015 | 4 | 0.030 |
Why?
|
Multifactorial Inheritance | 1 | 2024 | 1380 | 0.030 |
Why?
|
Color Perception Tests | 1 | 2015 | 12 | 0.030 |
Why?
|
Europe | 2 | 2018 | 3413 | 0.030 |
Why?
|
Pacific Islands | 1 | 2015 | 52 | 0.030 |
Why?
|
Socioeconomic Factors | 2 | 2020 | 7798 | 0.030 |
Why?
|
Darkness | 1 | 2015 | 158 | 0.030 |
Why?
|
Introns | 1 | 2018 | 968 | 0.030 |
Why?
|
Seasons | 1 | 2021 | 1518 | 0.030 |
Why?
|
Automation | 1 | 2017 | 585 | 0.030 |
Why?
|
Tomography | 2 | 2008 | 411 | 0.030 |
Why?
|
Developed Countries | 1 | 2018 | 450 | 0.030 |
Why?
|
Language | 1 | 2024 | 1541 | 0.030 |
Why?
|
Antimetabolites, Antineoplastic | 2 | 2012 | 645 | 0.030 |
Why?
|
Color | 1 | 2015 | 299 | 0.030 |
Why?
|
Hospital Costs | 1 | 2020 | 947 | 0.030 |
Why?
|
Interpersonal Relations | 1 | 2021 | 1438 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2024 | 5239 | 0.030 |
Why?
|
Hospitals, County | 1 | 2013 | 17 | 0.030 |
Why?
|
Microsurgery | 1 | 2019 | 793 | 0.030 |
Why?
|
Waiting Lists | 1 | 2018 | 764 | 0.030 |
Why?
|
Societies, Medical | 2 | 2015 | 3900 | 0.030 |
Why?
|
Hospital Administrators | 1 | 2013 | 57 | 0.030 |
Why?
|
Internship and Residency | 1 | 2013 | 5878 | 0.030 |
Why?
|
Glare | 1 | 2012 | 6 | 0.030 |
Why?
|
Social Class | 1 | 2021 | 1992 | 0.030 |
Why?
|
Timolol | 1 | 2012 | 51 | 0.030 |
Why?
|
Intubation, Intratracheal | 1 | 2020 | 1331 | 0.030 |
Why?
|
Endpoint Determination | 1 | 2015 | 590 | 0.020 |
Why?
|
Tropicamide | 1 | 2011 | 22 | 0.020 |
Why?
|
Tissue Adhesions | 1 | 2013 | 218 | 0.020 |
Why?
|
Waist Circumference | 1 | 2016 | 933 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2019 | 2114 | 0.020 |
Why?
|
Practice Guidelines as Topic | 2 | 2007 | 7389 | 0.020 |
Why?
|
Cognition Disorders | 2 | 2003 | 3979 | 0.020 |
Why?
|
Acetazolamide | 1 | 2011 | 96 | 0.020 |
Why?
|
Tears | 1 | 2013 | 251 | 0.020 |
Why?
|
Brain Diseases | 1 | 2020 | 1545 | 0.020 |
Why?
|
Walking | 1 | 2018 | 1197 | 0.020 |
Why?
|
Absorption | 1 | 2011 | 242 | 0.020 |
Why?
|
Cost of Illness | 1 | 2021 | 1935 | 0.020 |
Why?
|
Rural Health | 1 | 2012 | 296 | 0.020 |
Why?
|
GPI-Linked Proteins | 1 | 2012 | 469 | 0.020 |
Why?
|
Qualitative Research | 1 | 2021 | 3016 | 0.020 |
Why?
|
Cause of Death | 1 | 2021 | 3683 | 0.020 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2012 | 453 | 0.020 |
Why?
|
Pedigree | 1 | 2018 | 4539 | 0.020 |
Why?
|
Blood Pressure Monitors | 1 | 2010 | 33 | 0.020 |
Why?
|
Quinoxalines | 1 | 2012 | 296 | 0.020 |
Why?
|
Depression | 2 | 2020 | 8132 | 0.020 |
Why?
|
Sensory Deprivation | 1 | 2010 | 108 | 0.020 |
Why?
|
Body Weights and Measures | 1 | 2010 | 208 | 0.020 |
Why?
|
Signal Transduction | 1 | 2013 | 23416 | 0.020 |
Why?
|
Expert Testimony | 1 | 2012 | 364 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2015 | 802 | 0.020 |
Why?
|
Geography | 1 | 2012 | 652 | 0.020 |
Why?
|
Mortality | 1 | 2021 | 2899 | 0.020 |
Why?
|
Calcium Channels | 1 | 2013 | 620 | 0.020 |
Why?
|
Gene Library | 1 | 2012 | 1055 | 0.020 |
Why?
|
Ocular Hypotension | 1 | 2009 | 23 | 0.020 |
Why?
|
Nursing Staff, Hospital | 1 | 2013 | 348 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 2 | 2013 | 4058 | 0.020 |
Why?
|
Anthropometry | 1 | 2014 | 1338 | 0.020 |
Why?
|
Retinoscopy | 1 | 2009 | 26 | 0.020 |
Why?
|
Medication Errors | 1 | 2015 | 783 | 0.020 |
Why?
|
Metabolic Networks and Pathways | 1 | 2013 | 789 | 0.020 |
Why?
|
Medical Staff, Hospital | 1 | 2013 | 601 | 0.020 |
Why?
|
Body Constitution | 1 | 2009 | 273 | 0.020 |
Why?
|
RNA, Untranslated | 1 | 2012 | 456 | 0.020 |
Why?
|
Paresthesia | 1 | 2009 | 162 | 0.020 |
Why?
|
Ultraviolet Rays | 1 | 2013 | 1079 | 0.020 |
Why?
|
Surgical Wound Dehiscence | 1 | 2009 | 212 | 0.020 |
Why?
|
Thiophenes | 1 | 2012 | 569 | 0.020 |
Why?
|
Patient Discharge | 1 | 2020 | 3442 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2012 | 1185 | 0.020 |
Why?
|
Epidemiologic Research Design | 1 | 2010 | 368 | 0.020 |
Why?
|
Random Allocation | 1 | 2011 | 2392 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 2013 | 1300 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2011 | 12142 | 0.020 |
Why?
|
Insurance Coverage | 1 | 2018 | 1937 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2020 | 5293 | 0.020 |
Why?
|
Models, Theoretical | 2 | 2011 | 3567 | 0.020 |
Why?
|
Intraoperative Complications | 1 | 2013 | 1161 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2013 | 1504 | 0.020 |
Why?
|
Drug Combinations | 1 | 2012 | 2048 | 0.020 |
Why?
|
Phenotype | 2 | 2014 | 16571 | 0.020 |
Why?
|
Wounds and Injuries | 1 | 2018 | 2491 | 0.020 |
Why?
|
Carbonic Anhydrase Inhibitors | 1 | 2005 | 91 | 0.020 |
Why?
|
Perfusion | 1 | 2010 | 1373 | 0.020 |
Why?
|
Forecasting | 1 | 2014 | 2924 | 0.020 |
Why?
|
Adrenergic alpha-Agonists | 1 | 2005 | 177 | 0.010 |
Why?
|
Macular Edema | 1 | 2009 | 374 | 0.010 |
Why?
|
Artifacts | 1 | 2013 | 1910 | 0.010 |
Why?
|
Self Administration | 1 | 2005 | 387 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 12966 | 0.010 |
Why?
|
Genetic Loci | 1 | 2013 | 2624 | 0.010 |
Why?
|
Vitamin A Deficiency | 1 | 2003 | 88 | 0.010 |
Why?
|
Eye Infections | 1 | 2003 | 62 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2012 | 6074 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2012 | 2413 | 0.010 |
Why?
|
Sulfonamides | 1 | 2012 | 1977 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12447 | 0.010 |
Why?
|
Recovery of Function | 1 | 2011 | 2978 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2014 | 3954 | 0.010 |
Why?
|
Australia | 1 | 2004 | 1248 | 0.010 |
Why?
|
Genome, Human | 1 | 2013 | 4421 | 0.010 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2005 | 1241 | 0.010 |
Why?
|
Surgical Flaps | 1 | 2007 | 1670 | 0.010 |
Why?
|
Models, Biological | 2 | 2004 | 9461 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2013 | 9417 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2012 | 12758 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2013 | 7847 | 0.010 |
Why?
|
Lipids | 1 | 2007 | 3332 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2012 | 11874 | 0.010 |
Why?
|
Obesity | 1 | 2016 | 12933 | 0.010 |
Why?
|
Coronary Disease | 1 | 2004 | 5912 | 0.010 |
Why?
|